DO MYELOPROLIFERATIVE NEOPLASMS (MPNS) HAVE STAGES? ANALYSIS OF RELATIONSHIP OF DISEASE DURATION, PROGNOSTIC SCORES, AND SYMPTOMATIC BURDEN OF 1467 MPN PATIENTS

被引：0

作者：

Geyer, H. ^{[1
]}

Emanuel, R. ^{[1
]}

Dueck, A. ^{[2
]}

Kiladjian, J. ^{[3
]}

Slot, S. ^{[4
]}

Zweegman, S. ^{[4
]}

te Boekhorst, P. ^{[5
]}

Commandeur, S. ^{[6
]}

Schouten, H. ^{[7
]}

Sackmann, F. ^{[8
]}

Fuentes, A. ^{[9
]}

Hernandez-Maraver, D. ^{[9
]}

Pahl, H. ^{[10
]}

Griesshammer, M. ^{[11
]}

Stegelmann, F. ^{[12
]}

Dohner, K. ^{[12
]}

Lehmann, T. ^{[13
]}

Bonatz, K. ^{[14
]}

Boyer, F. ^{[15
]}

Etienne, G. ^{[16
]}

Ianotto, J. ^{[17
]}

Ranta, D. ^{[18
]}

Roy, L. ^{[19
]}

Cahn, J. ^{[20
]}

Harrison, C. ^{[21
]}

Radia, D. ^{[21
]}

Muxi, P. ^{[22
]}

Maldonado, N. ^{[23
]}

Besses, Ca ^{[24
]}

Cervantes, F. ^{[25
]}

Johansson, P. ^{[26
]}

Barbui, T. ^{[27
]}

Barosi, G. ^{[28
]}

Vannucchi, A. ^{[29
]}

Passamonti, F. ^{[30
]}

Andreasson, B. ^{[31
]}

Ferrari, M. ^{[32
]}

Rambaldi, A. ^{[27
]}

Samuelsson, J. ^{[33
]}

Birgegard, G. ^{[34
]}

Xiao, Z. ^{[35
,36
]}

Xu, Z. ^{[37
]}

Zhang, Y. ^{[38
]}

Sun, X. ^{[39
]}

Xu, J. ^{[39
]}

Zhang, P. ^{[40
]}

Gale, R. ^{[41
]}

Mesa, R. ^{[42
]}

机构：

[1] Mayo Clin, Internal Med, Scottsdale, AZ USA

[2] Mayo Clin, Biostat, Scottsdale, AZ USA

[3] Hosp St Louis, Clin Invest Ctr, Paris, France

[4] Vrije Univ Amsterdam Med Ctr, Hematol, Amsterdam, Netherlands

[5] Erasmus MC, Hematol, Rotterdam, Netherlands

[6] LUMC, Dermatol, Leiden, Netherlands

[7] MUMC, Hematol, Maastricht, Netherlands

[8] Fundaleu, Buenos Aires, DF, Argentina

[9] Univ Hosp La Paz, Hematol, Madrid, Spain

[10] Univ Hosp Freiburg, Expt Anaesthesiol, Freiburg, Germany

[11] Univ Hosp Freiburg, Expt Haematol, Freiburg, Germany

[12] Univ Hosp Ulm, Internal Med, Ulm, Germany

[13] Univ Hosp, Hematol, Basel, Switzerland

[14] Univ Med, Med Klin, Mannheim, Germany

[15] Ctr Hosp Univ, Angers, France

[16] Inst Bergonie, Bordeaux, France

[17] Ctr Hosp Univ, Brest, France

[18] Hosp Univ, Nancy, France

[19] Ctr Hosp Univ, Poitiers, France

[20] Ctr Hosp Univ, Grenoble, France

[21] Guys & St Thomas NHS Fdn Trust, Haematol, London, England

[22] Hosp Britan, Unidadde Hematol, Montevideo, Uruguay

[23] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA

[24] Hosp del Mar, Hematol, Barcelona, Spain

[25] Univ Barcelona, IDIBAPS, Hosp Clin, Hematol, Barcelona, Spain

[26] NU Hosp Org, Internal Med, Uddevalla, Sweden

[27] Osped Riuniti Bergamo, Hematol, Bergamo, Italy

[28] IRCCS Policlin S Matteo Fdn, Lab Clin Epidemiol, Pavia, Italy

[29] Univ Florence, Hematol, Florence, Italy

[30] Univ Pavia, Hematol, Pavia, Italy

[31] NU Hosp Org, Internal Med, Uddevella, Sweden

[32] Osped Riuniti Bergamo, Biol Sci, Bergamo, Italy

[33] Stockholm South Hosp, Internal Med, Stockholm, Sweden

[34] Univ Hosp, Hematol, Uppsala, Sweden

[35] Chinese Acad Med Sci, MDS & MPN Ctr, Beijing, Peoples R China

[36] Peking Union Med Coll, Beijing, Peoples R China

[37] Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China

[38] Inst Hematol, MDS & MPN Ctr, Tianjin, Peoples R China

[39] Inst Hematol & Blood Dis Hosp, MDS & MPN Ctr, Tianjin, Peoples R China

[40] Inst Hematol & Blood Dis Hosp, Dept Pathol, Tianjin, Peoples R China

[41] Imperial Coll, London, England

[42] Mayo Clin, Hematol, Scottsdale, AZ USA

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P266

引用

页码：114 / 115

页数：2

共 10 条

[1] Impact of Disease Duration upon Symptom Burden Amongst Patients with Myeloproliferative Neoplasms (MPNs)
Scherber, Robyn M.
Geyer, Holly
Harrison, Claire N.
Kosiorek, Heidl E.
Dueck, Amylou C.
Kiladjian, Jean-Jacques
Slot, Stefanie
Xiao, Zhijian
Zweegman, Sonja
Sackmann, Federico
Kerguelen Fuentes, Ana
Hernandez-Maraver, Dolores
Doehner, Konstanze
Radia, Deepti
Muxi, Pablo J.
Besses, Carlos
Cervantes, Francisco
Johansson, Peter L.
Andreasson, Bjorn
Rambaldi, Alessandro
Barbui, Tiziano
Bonatz, Karin
Reiter, Andreas
Boyer, Francoise
Etienne, Gabriel
Ianotto, Jean-Christophe
Ranta, Dana
Roy, Jean
Cahn, Jean-Yves
Maldonado, Norman I.
Barosi, Giovanni
Ferrari, Maria
Gale, Robert Peter
Birgegard, Gunnar
Xu, Zefeng
Zhang, Yu
Sun, Xiujuan
Xu, Junqing
Zhang, Peihong
te Boekhorst, Peter A.
Commandeur, Suzan
Schouten, Harry C.
Pahl, Heike L.
Griesshammer, Martin
Stegelmann, Frank
Lehmann, Thomas
Vannucchi, Alessandro M.
Passamonti, Francesco
Samuelsson, Jan
Mesa, Ruben A.
BLOOD, 2015, 126 (23)
[2] Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey
Mesa, Ruben
Miller, Carole B.
Thyne, Maureen
Mangan, James
Goldberger, Sara
Fazal, Salman
Ma, Xiaomei
Wilson, Wendy
Paranagama, Dilan C.
Dubinski, David G.
Boyle, John
Mascarenhas, John O.
BMC CANCER, 2016, 16
[3] Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey
Ruben Mesa
Carole B. Miller
Maureen Thyne
James Mangan
Sara Goldberger
Salman Fazal
Xiaomei Ma
Wendy Wilson
Dilan C. Paranagama
David G. Dubinski
John Boyle
John O. Mascarenhas
BMC Cancer, 16
[4] Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey
Yu, Jingbo
Paranagama, Dilan
Geyer, Holly L.
Parasuraman, Shreekant
Mesa, Ruben
ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1119 - 1125
[5] Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey
Jingbo Yu
Dilan Paranagama
Holly L. Geyer
Shreekant Parasuraman
Ruben Mesa
Annals of Hematology, 2019, 98 : 1119 - 1125
[6] Work Productivity Impairment and Symptom Burden among Patients with Myeloproliferative Neoplasms (MPNs): Findings from the Living with MPN Patient Survey
Yu, Jingbo
Paranagama, Dilan
Bai, Andrew
Parasuraman, Shreekant
Mesa, Ruben
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S355 - S356
[7] Role of Symptom Burden in Disability Leave Among Patients with Myeloproliferative Neoplasms (MPNs): Findings from the Living with MPN Patient Survey
Yu, Jingbo
Paranagama, Dilan Chamikara
Geyer, Holly L.
Parasuraman, Shreekant V.
Mesa, Ruben A.
BLOOD, 2017, 130
[8] Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group
Geyer, Holly L.
Kosiorek, Heidi
Dueck, Amylou C.
Scherber, Robyn
Slot, Stefanie
Zweegman, Sonja
te Boekhorst, Peter A. W.
Senyak, Zhenya
Schouten, Harry C.
Sackmann, Federico
Kerguelen Fuentes, Ana
Hernandez-Maraver, Dolores
Pahl, Heike L.
Griesshammer, Martin
Stegelmann, Frank
Doehner, Konstanze
Lehmann, Thomas
Bonatz, Karin
Reiter, Andreas
Boyer, Francoise
Etienne, Gabriel
Ianotto, Jean-Christophe
Ranta, Dana
Roy, Lydia
Cahn, Jean-Yves
Harrison, Claire N.
Radia, Deepti
Muxi, Pablo
Maldonado, Norman
Besses, Carlos
Cervantes, Francisco
Johansson, Peter L.
Barbui, Tiziano
Barosi, Giovanni
Vannucchi, Alessandro M.
Paoli, Chiara
Passamonti, Francesco
Andreasson, Bjorn
Ferrari, Maria L.
Rambaldi, Alessandro
Samuelsson, Jan
Cannon, Keith
Birgegard, Gunnar
Xiao, Zhijian
Xu, Zefeng
Zhang, Yue
Sun, Xiujuan
Xu, Junqing
Kiladjian, Jean-Jacques
Zhang, Peihong
HAEMATOLOGICA, 2017, 102 (01) : 85 - 93
[9] Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey
Mesa, Ruben A.
Miller, Carole B.
Thyne, Maureen
Mangan, James
Goldberger, Sara
Fazal, Salman
Ma, Xiaomei
Wilson, Wendy
Paranagama, Dilan C.
Dubinski, David G.
Naim, Ahmad
Parasuraman, Shreekant
Boyle, John
Mascarenhas, John O.
CANCER, 2017, 123 (03) : 449 - 458
[10] QUANTIFICATION OF THE JAK2V617F ALLELE BURDEN BY DROPLET DIGITAL PCR (DDPCR): APPLICATION TO MINIMAL RESIDUAL DISEASE (MRD) EVALUATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS AFFECTED BY MYELOPROLIFERATIVE NEOPLASMS (MPN)
Salmoiraghi, S.
Belotti, C.
Finazzi, M. C.
Mico, M. C.
Algarotti, A.
Finazzi, G.
Mascheroni, M.
Salvi, A.
Rambaldi, A.
Spinelli, O.
HAEMATOLOGICA, 2016, 101 : S46 - S46

← 1 →